Department of Dermatology, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
Department of Anatomy, Southwest Medical University, Luzhou, People's Republic of China.
Redox Rep. 2022 Dec;27(1):200-211. doi: 10.1080/13510002.2022.2123841.
Inflammation and oxidative stress (OS) are important contributors to psoriasis pathogenesis. Proanthocyanidins (PCs) have anti-inflammatory and anti-oxidative activities. Previously, we discovered that PCs alleviated psoriasis-like mice symptoms, likely via mitigating inflammation and OS damage.
To elucidate the protective mechanism underlying PCs against the damage of TNF-ɑ-induced psoriasis-like cell models.
Psoriasis-like cell models were established with 7.5 ng/mL TNF-ɑ and then subjected to different-concentrations PCs treatment. Finally, inflammatory and oxidative parameters were determined. Besides, LY294002 (PI3K inhibitor) and ZnPP (HO-1 inhibitor) were employed to investigate the roles of PI3K/AKT and HO-1 in PCs against psoriasis-like cell models.
After TNF-α treatment, cells organized tightly and proliferated greatly (P<0.01); HO-1 expression dropped obviously, along with the increased OS/inflammatory indicators and the decreased antioxidants (P<0.05); consequently, psoriasis-like cell models were well established. In the presence of PCs, nevertheless, the proliferation rate and number of psoriasis-like cells evidently decreased (P<0.01), accompanied with enhanced HO-1 and antioxidants, and lowered OS/inflammatory indicators as well as phosphorylated JAK2/STAT3/PI3/AKT (P<0.01). Similar changes appeared after LY294002 pretreatment, regardless of PCs or not. But after ZnPP pretreatment with or without PCs, the opposite occurred.
The study reveals that PCs can suppress psoriasis-like cell proliferation and reduce inflammatory/OS damage through PI3K/AKT inhibition and HO-1 activation, thus promising a candidate for PCs in treating psoriasis.
炎症和氧化应激(OS)是银屑病发病机制的重要因素。原花青素(PCs)具有抗炎和抗氧化作用。此前,我们发现 PCs 缓解了银屑病样小鼠的症状,可能是通过减轻炎症和 OS 损伤。
阐明 PCs 对 TNF-α诱导的银屑病样细胞模型损伤的保护机制。
用 7.5ng/mL TNF-α建立银屑病样细胞模型,然后用不同浓度的 PCs 处理。最后,测定炎症和氧化参数。此外,还使用 LY294002(PI3K 抑制剂)和 ZnPP(HO-1 抑制剂)来研究 PI3K/AKT 和 HO-1 在 PCs 对银屑病样细胞模型中的作用。
TNF-α处理后,细胞紧密排列,增殖明显(P<0.01);HO-1 表达明显下降,同时 OS/炎症指标升高,抗氧化剂减少(P<0.05);因此,银屑病样细胞模型建立良好。然而,在 PCs 的存在下,银屑病样细胞的增殖率和数量明显降低(P<0.01),同时 HO-1 和抗氧化剂增强,OS/炎症指标以及磷酸化 JAK2/STAT3/PI3/AKT 降低(P<0.01)。无论是否存在 PCs,用 LY294002 预处理后都会出现类似的变化。但是,在用 ZnPP 预处理后,无论是否存在 PCs,结果都相反。
该研究表明,PCs 可以通过抑制 PI3K/AKT 和激活 HO-1 来抑制银屑病样细胞增殖,减少炎症/OS 损伤,有望成为治疗银屑病的 PCs 候选药物。